Cellares vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) for cell therapy, automating end-to-end CAR-T and cell therapy production; raised $257M Series D in 2026 led by BlackRock and Eclipse;
About
Cellares is a clinical-stage biotech and contract manufacturing company founded in 2019 by Fabian Gerlinghaus, James Cha, and Yi Zhao, headquartered in South San Francisco, California. The company has built the world''s first fully automated, integrated cell therapy manufacturing platform — the Cell Shuttle — which automates the entire end-to-end process of manufacturing patient-specific T-cell therapies (including CAR-T cells) in a single closed system. Traditional cell therapy manufacturing is highly manual, requiring highly trained technicians, specialized cleanroom infrastructure, and weeks of labor-intensive processing. Cellares replaces this with industrial-scale automation, compressing production timelines and dramatically reducing the cost and variability of cell therapy manufacturing.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.